Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Testosterone and Alendronate in Hypogonadal Men

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2016 by Massachusetts General Hospital
Sponsor:
Collaborators:
Endo Pharmaceuticals
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Benjamin Leder, MD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01460654
First received: October 20, 2011
Last updated: April 7, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2016
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)